tiprankstipranks
Enliven Therapeutics, Inc. (ELVN)
NASDAQ:ELVN
US Market
ELVN
Enliven Therapeutics
RESEARCH TOOLSreports

Enliven Therapeutics (ELVN) Balance Sheet

331 Followers

Enliven Therapeutics Balance Sheet

Enliven Therapeutics's total assets for Q4 2025 were $476.17M, a decrease of -3.00% from the previous quarter. ELVN total liabilities were $16.68M for the fiscal quarter, a 13.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 476.17M$ 325.76M$ 271.87M$ 83.30M$ 113.33M
Total Liabilities
$ 16.68M$ 15.91M$ 25.96M$ 160.12M$ 6.47M
Total Equity Gross Minority
$ 459.60M$ 309.85M$ 245.91M$ -76.83M$ 106.86M
Other Metrics
Currency in USD

Enliven Therapeutics Debt to Assets